Published in Leukemia on November 08, 2011
SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells. Cell Stem Cell (2014) 1.73
Targeting p53 by small molecules in hematological malignancies. J Hematol Oncol (2013) 1.23
Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy. Leukemia (2013) 1.00
Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications. Int J Biol Sci (2014) 0.96
BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1. Cancer Med (2013) 0.96
TPEN induces apoptosis independently of zinc chelator activity in a model of acute lymphoblastic leukemia and ex vivo acute leukemia cells through oxidative stress and mitochondria caspase-3- and AIF-dependent pathways. Oxid Med Cell Longev (2012) 0.94
Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents. Clin Epigenetics (2013) 0.93
Use of rodents as models of human diseases. J Pharm Bioallied Sci (2014) 0.87
MDM2 antagonists synergize broadly and robustly with compounds targeting fundamental oncogenic signaling pathways. Oncotarget (2014) 0.86
Green tea polyphenols induce p53-dependent and p53-independent apoptosis in prostate cancer cells through two distinct mechanisms. PLoS One (2012) 0.86
Targeting p53-MDM2-MDMX loop for cancer therapy. Subcell Biochem (2014) 0.85
Synergistic anti-tumour effects of tetrandrine and chloroquine combination therapy in human cancer: a potential antagonistic role for p21. Br J Pharmacol (2015) 0.84
First in-mouse development and application of a surgically relevant xenograft model of ovarian carcinoma. PLoS One (2014) 0.83
Cross-species functional genomic analysis identifies resistance genes of the histone deacetylase inhibitor valproic acid. PLoS One (2012) 0.82
4-Alkylated Silver-N-Heterocyclic Carbene (NHC) Complexes with Cytotoxic Effects in Leukemia Cells. ChemMedChem (2015) 0.78
Establishment of a bioluminescence model for microenvironmentally induced oral carcinogenesis with implications for screening bioengineered scaffolds. Head Neck (2015) 0.78
Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in acute myeloid leukemia (AML). Oncotarget (2016) 0.77
Molecular mechanisms of nutlin-3 involve acetylation of p53, histones and heat shock proteins in acute myeloid leukemia. Mol Cancer (2014) 0.76
The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma. Oncotarget (2016) 0.76
Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinic. Expert Rev Hematol (2014) 0.76
Anti-proliferative activity of the NPM1 interacting natural product avrainvillamide in acute myeloid leukemia. Cell Death Dis (2016) 0.75
Hydroxyurea synergizes with valproic acid in wild-type p53 acute myeloid leukaemia. Oncotarget (2016) 0.75
Functional p53 is required for rapid restoration of daunorubicin-induced lesions of the spleen. BMC Cancer (2013) 0.75
Upregulation of SOCS-1 by Nutlin-3 in acute myeloid leukemia cells but not in primary normal cells. Clinics (Sao Paulo) (2014) 0.75
Cyanobacteria from terrestrial and marine sources contain apoptogens able to overcome chemoresistance in acute myeloid leukemia cells. Mar Drugs (2014) 0.75
RNA recognition by a Staufen double-stranded RNA-binding domain. EMBO J (2000) 3.12
Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene (2010) 3.05
Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet (1991) 2.72
Miranda mediates asymmetric protein and RNA localization in the developing nervous system. Genes Dev (1998) 2.13
Improved FACS-Gal: flow cytometric analysis and sorting of viable eukaryotic cells expressing reporter gene constructs. Cytometry (1991) 1.99
Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis. Am J Hum Genet (1997) 1.94
Fine mapping of 28S rRNA sites specifically cleaved in cells undergoing apoptosis. Mol Cell Biol (1995) 1.78
Dominant effector genetics in mammalian cells. Nat Genet (2001) 1.68
Histone deacetylase inhibitors in cancer treatment: a review of the clinical toxicity and the modulation of gene expression in cancer cell. Curr Pharm Biotechnol (2007) 1.61
The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. Exp Cell Res (1991) 1.55
Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J Exp Med (1997) 1.55
Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease. Br J Haematol (2001) 1.49
Erythropoietin a safe bet in haemorrhagic shock? Acta Anaesthesiol Scand (2008) 1.39
[A management program for primary thrombocytopenia]. Tidsskr Nor Laegeforen (1999) 1.38
New strategies in the treatment of acute myelogenous leukemia: mobilization and transplantation of autologous peripheral blood stem cells in adult patients. Stem Cells (2000) 1.38
Quantitative measurement of mast cell degranulation using a novel flow cytometric annexin-V binding assay. Cytometry (1999) 1.32
The genetic subtypes of cAMP-dependent protein kinase--functionally different or redundant? Biochim Biophys Acta (1993) 1.17
Review: genetic models of acute myeloid leukaemia. Oncogene (2008) 1.14
Programmed cell death (apoptosis) is induced rapidly and with positive cooperativity by activation of cyclic adenosine monophosphate-kinase I in a myeloid leukemia cell line. J Cell Physiol (1991) 1.12
Breast cancer prognostication and prediction in the postgenomic era. Ann Oncol (2007) 1.11
Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors. Cell Death Differ (1999) 1.06
Neurokinin-3 receptor distribution in rat and human brain: an immunohistochemical study. Neuroscience (1999) 1.03
Heat shock protein 90 - a potential target in the treatment of human acute myelogenous leukemia. Curr Cancer Drug Targets (2009) 1.02
Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients. Leukemia (2013) 1.00
Animal models of acute myelogenous leukaemia - development, application and future perspectives. Leukemia (2005) 0.99
Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia. Oncogene (2011) 0.96
Caspase-dependent, geldanamycin-enhanced cleavage of co-chaperone p23 in leukemic apoptosis. Leukemia (2004) 0.95
Cleaved intracellular plasminogen activator inhibitor 2 in human myeloleukaemia cells is a marker of apoptosis. Br J Cancer (1994) 0.95
New strategies in the treatment of acute myelogenous leukemia (AML): in vitro culture of aml cells--the present use in experimental studies and the possible importance for future therapeutic approaches. Stem Cells (2001) 0.94
Acute myelogenous leukemia in a patient with Li-Fraumeni syndrome treated with valproic acid, theophyllamine and all-trans retinoic acid: a case report. Leukemia (2006) 0.93
Microinjected catalytic subunit of cAMP-dependent protein kinase induces apoptosis in myeloid leukemia (IPC-81) cells. Exp Cell Res (1993) 0.92
A novel brain metastases model developed in immunodeficient rats closely mimics the growth of metastatic brain tumours in patients. Neuropathol Appl Neurobiol (2011) 0.92
Mapping genetic alterations causing chemoresistance in cancer: identifying the roads by tracking the drivers. Oncogene (2013) 0.91
Patterns of cell death induced by eluates from denture base acrylic resins in U-937 human monoblastoid cells. Eur J Oral Sci (2000) 0.90
Antiapoptotic effect of heterozygously expressed mutant RI (Ala336-->Asp) subunit of cAMP kinase I in a rat leukemia cell line. J Biol Chem (1993) 0.90
CaM-kinaseII-dependent commitment to microcystin-induced apoptosis is coupled to cell budding, but not to shrinkage or chromatin hypercondensation. Cell Death Differ (2005) 0.90
Fas/APO-1(CD95)-induced apoptosis of primary hepatocytes is inhibited by cAMP. Biochem Biophys Res Commun (1997) 0.90
A termination mutant prevalent in Norwegian haplotype 7 phenylketonuria genes. Am J Hum Genet (1990) 0.90
8-Chloro-cAMP induces apoptotic cell death in a human mammary carcinoma cell (MCF-7) line. Br J Cancer (1995) 0.90
Catha edulis (Khat) induces cell death by apoptosis in leukemia cell lines. Ann N Y Acad Sci (2003) 0.90
Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis. Cell Death Dis (2013) 0.89
Khat (Catha edulis)-induced apoptosis is inhibited by antagonists of caspase-1 and -8 in human leukaemia cells. Br J Cancer (2004) 0.88
Mdm2 controls CREB-dependent transactivation and initiation of adipocyte differentiation. Cell Death Differ (2012) 0.88
Specific cellular signal-transduction responses to in vivo combination therapy with ATRA, valproic acid and theophylline in acute myeloid leukemia. Blood Cancer J (2011) 0.87
In vitro culture of human acute myelogenous leukemia (AML) cells in serum-free media: studies of native AML blasts and AML cell lines. J Hematother Stem Cell Res (2000) 0.86
Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis. J Eur Acad Dermatol Venereol (1998) 0.85
Insulin-like growth factor-1 (IGF-1) has a costimulatory effect on proliferation of committed progenitors derived from human umbilical cord CD34+ cells. Stem Cells (1998) 0.85
Tunneling nanotube (TNT) formation is independent of p53 expression. Cell Death Differ (2013) 0.84
Cyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcription. Cell Death Dis (2011) 0.84
A novel paired domain DNA recognition motif can mediate Pax2 repression of gene transcription. Biochem Biophys Res Commun (1999) 0.84
Embryonic expression and DNA-binding properties of zebrafish pax-6. Biochem Biophys Res Commun (1995) 0.84
Characterization of ribosomal P autoantibodies in relation to cell destruction and autoimmune disease. Scand J Immunol (2004) 0.84
Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells. Transfusion (2005) 0.84
Implications of cell death regulation in the pathogenesis and treatment of prostate cancer. Semin Oncol (1999) 0.83
Identification of four SB antigens by cloned cells. Population studies of Norwegians. Tissue Antigens (1983) 0.83
Restoration of bax in prostate cancer suppresses tumor growth and augments therapeutic cell death induction. Anticancer Res (2002) 0.83
Molecular cloning and characterization of anionic and cationic variants of trypsin from Atlantic salmon. Eur J Biochem (1995) 0.83
No differences in colony formation of peripheral blood stem cells frozen with 5% or 10% dimethyl sulfoxide. J Hematother Stem Cell Res (2003) 0.82
HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects. Diabetologia (1985) 0.82
New strategies for the treatment of acute myelogenous leukemia: differentiation induction--present use and future possibilities. Stem Cells (2000) 0.82
Ribosomal proteins sustain morphology, function and phenotype in acute myeloid leukemia blasts. Leuk Res (1998) 0.81
Induction of differentiation and apoptosis- a possible strategy in the treatment of adult acute myelogenous leukemia. Oncologist (2000) 0.81
Caspase I-related protease inhibition retards the execution of okadaic acid- and camptothecin-induced apoptosis and PAI-2 cleavage, but not commitment to cell death in HL-60 cells. Br J Cancer (1999) 0.81
The Atlantic salmon prepro-gonadotropin releasing hormone gene and mRNA. Mol Cell Endocrinol (1992) 0.81
In vitro effects of insulin-like growth factor-1 (IGF-1) on proliferation and constitutive cytokine secretion by acute myelogenous leukemia blasts. Eur J Haematol (1999) 0.81
T lymphocyte responses to Coxsackie B4 and mumps virus. I. Influence of HLA-DR restriction elements. Tissue Antigens (1985) 0.80
Flow cytometric measurement of apoptosis and necrosis in cryopreserved PBPC concentrates from patients with malignant diseases. Bone Marrow Transplant (2002) 0.80
Age and species-dependent differences in the neurokinin B system in rat and human brain. Neurobiol Aging (1999) 0.80
Pancreatic carboxylester lipase from Atlantic salmon (Salmo salar). cDNA sequence and computer-assisted modelling of tertiary structure. Eur J Biochem (1994) 0.79
Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-alpha. Leuk Lymphoma (1995) 0.79
Interleukin 2- and interferon-production and expression of interleukin 2 receptors by human mononuclear cells stimulated with mumps virus or phytohaemagglutinin. Acta Pathol Microbiol Immunol Scand C (1986) 0.79
The role of the CD8-positive subset of T cells in proliferative responses to soluble antigens. I. Studies of healthy subjects, type 1 diabetics, and coeliac disease patients. Scand J Immunol (1986) 0.79
Sensitive and rapid detection of beta-galactosidase expression in intact cells by microinjection of fluorescent substrate. Exp Cell Res (1995) 0.79
Gap junctions and growth control in liver regeneration and in isolated rat hepatocytes. Hepatology (1997) 0.78
Circadian variations do not have a major impact on serum levels of soluble (S) L-selectin (CD63L), S-intercellular adhesion molecule 1 (sICAM-1/CD54) and thrombopoietin in healthy individuals. Scand J Clin Lab Invest (2002) 0.78
The effect of heat- and auto-polymerized denture base polymers on clonogenicity, apoptosis, and necrosis in fibroblasts: denture base polymers induce apoptosis and necrosis. Acta Odontol Scand (2000) 0.78
T lymphocyte responses to Coxsackie B4 and mumps virus. II. Immunoregulation by HLA-DR3 and -DR4 associated restriction elements. Tissue Antigens (1985) 0.77
HLA control of the proliferative T lymphocyte response to antigenic determinants on mumps virus. Studies of healthy individuals and patients with type 1 diabetes. Scand J Immunol (1985) 0.77
The proliferative T-lymphocyte response to streptokinase. J Clin Lab Immunol (1986) 0.76
Biotechnology in aquaculture, with special reference to transgenic salmon. Biotechnol Genet Eng Rev (1993) 0.76
Genomic HLA-DQ beta polymorphism associated with insulin-dependent diabetes mellitus. Analysis of possible functional significance. Scand J Immunol (1987) 0.76
Tumor-specific antigens revisited: presentation to the immune system of fusion peptides resulting solely from tumor-specific chromosomal translocations. Oncol Res (1992) 0.76
The complete nucleotide sequence of the Atlantic salmon growth hormone I gene. Biochim Biophys Acta (1992) 0.75
Serum thrombopoietin levels in acute leukemia patients with chemotherapy-induced cytopenia--inverse correlation between serum levels and platelet counts. Leukemia (1998) 0.75
Can dipyridamole or verapamil slow regrowth of leukaemia cells? Leuk Res (1992) 0.75
High dose ara-C combined with autologous peripheral blood stem cell transplantation in the treatment of acute myelogenous leukemia: the question is still not answered. Stem Cells (2000) 0.75
Serum levels of soluble ICAM-1 in acute leukemia patients with chemotherapy-induced neutropenia. Leukemia (1997) 0.75
Reduction of coronary artery bypass graft occlusion by dipyridamol--is immunosuppression important? Clin Immunol Immunopathol (1988) 0.75
[The medical leech--Hirudo medicinalis. Natural occurrence, medical use and complications]. Tidsskr Nor Laegeforen (1987) 0.75
Studies on the HLA association to insulin-dependent diabetes mellitus (IDDM). Pol Arch Med Wewn (1990) 0.75